Healiva

Around 25% of diabetic patients and 3% of the elderly suffer from chronic wounds, with many remaining unhealed due to ineffective treatments. Healiva is a patient-centric biotech company that develops a portfolio of innovative and scalable solutions, ranging from enzymatic debriding agents to personalised cell therapies. The startup operates as a B2B business, primarily working with clinics, hospitals, and insurance companies, while partnering with various industry players to deliver therapies to patients efficiently.